• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奖赏缺乏综合征(RDS)令人惊讶地具有进化性且随处可见:它是“在风中飘荡”吗?

Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?

作者信息

Blum Kenneth, McLaughlin Thomas, Bowirrat Abdalla, Modestino Edward J, Baron David, Gomez Luis Llanos, Ceccanti Mauro, Braverman Eric R, Thanos Panayotis K, Cadet Jean Lud, Elman Igor, Badgaiyan Rajendra D, Jalali Rehan, Green Richard, Simpatico Thomas A, Gupta Ashim, Gold Mark S

机构信息

Division of Addiction Research & Education, Center for Psychiatry, Medicine, & Primary Care (Office of the Provost), Graduate College, Western University of Health Sciences, Pomona, CA 91766, USA.

Institute of Psychology, ELTE Eötvös Loránd University, 1075 Budapest, Hungary.

出版信息

J Pers Med. 2022 Feb 21;12(2):321. doi: 10.3390/jpm12020321.

DOI:
10.3390/jpm12020321
PMID:35207809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8875142/
Abstract

Reward Deficiency Syndrome (RDS) encompasses many mental health disorders, including a wide range of addictions and compulsive and impulsive behaviors. Described as an octopus of behavioral dysfunction, RDS refers to abnormal behavior caused by a breakdown of the cascade of reward in neurotransmission due to genetic and epigenetic influences. The resultant reward neurotransmission deficiencies interfere with the pleasure derived from satisfying powerful human physiological drives. Epigenetic repair may be possible with precision gene-guided therapy using formulations of KB220, a nutraceutical that has demonstrated pro-dopamine regulatory function in animal and human neuroimaging and clinical trials. Recently, large GWAS studies have revealed a significant dopaminergic gene risk polymorphic allele overlap between depressed and schizophrenic cohorts. A large volume of literature has also identified ADHD, PTSD, and spectrum disorders as having the known neurogenetic and psychological underpinnings of RDS. The hypothesis is that the true phenotype is RDS, and behavioral disorders are endophenotypes. Is it logical to wonder if RDS exists everywhere? Although complex, "the answer is blowin' in the wind," and rather than intangible, RDS may be foundational in species evolution and survival, with an array of many neurotransmitters and polymorphic loci influencing behavioral functionality.

摘要

奖赏缺乏综合征(RDS)涵盖多种心理健康障碍,包括广泛的成瘾行为以及强迫和冲动行为。RDS被描述为行为功能障碍的章鱼,指的是由于遗传和表观遗传影响导致神经传递中奖赏级联中断所引起的异常行为。由此产生的奖赏神经传递缺陷会干扰从满足强大的人类生理驱力中获得的愉悦感。使用营养保健品KB220制剂进行精确基因引导治疗可能实现表观遗传修复,KB220在动物和人类神经影像学及临床试验中已显示出促多巴胺调节功能。最近,大规模全基因组关联研究(GWAS)表明,抑郁症和精神分裂症队列之间存在显著的多巴胺能基因风险多态性等位基因重叠。大量文献还将注意力缺陷多动障碍(ADHD)、创伤后应激障碍(PTSD)和谱系障碍确定为具有RDS已知的神经遗传学和心理学基础。假说认为真正的表型是RDS,而行为障碍是内表型。不禁要问,RDS是否无处不在?尽管复杂,但“答案在风中飘荡”,而且RDS并非无形,它可能在物种进化和生存中具有基础性作用,有一系列神经递质和多态性位点影响行为功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a011/8875142/4d6953b8c24a/jpm-12-00321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a011/8875142/b44c762754c8/jpm-12-00321-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a011/8875142/a3b175df8eb4/jpm-12-00321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a011/8875142/4d6953b8c24a/jpm-12-00321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a011/8875142/b44c762754c8/jpm-12-00321-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a011/8875142/a3b175df8eb4/jpm-12-00321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a011/8875142/4d6953b8c24a/jpm-12-00321-g003.jpg

相似文献

1
Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?奖赏缺乏综合征(RDS)令人惊讶地具有进化性且随处可见:它是“在风中飘荡”吗?
J Pers Med. 2022 Feb 21;12(2):321. doi: 10.3390/jpm12020321.
2
Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?奖励缺陷综合征(RDS)是否应被视为精神疾病以及相关基因和表观遗传诱导的脑奖励回路失调的一种综合性病症?
J Pers Med. 2022 Oct 14;12(10):1719. doi: 10.3390/jpm12101719.
3
Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.奖赏缺乏综合征(RDS):所有成瘾行为的一种细胞结构共同神经生物学特征。
Int J Environ Res Public Health. 2021 Nov 2;18(21):11529. doi: 10.3390/ijerph182111529.
4
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.寻找无奖赏缺乏综合征(RDS)的对照:基因成瘾风险测试中的“圣杯”。
Curr Psychopharmacol. 2020;9(1):7-21.
5
A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management".关于DNA风险等位基因的综述,以确定mRNA表达的表观遗传修复,从而证明在奖赏缺乏综合征(RDS)中的治疗效果:采用“精准行为管理”
Psychol Res Behav Manag. 2021 Dec 17;14:2115-2134. doi: 10.2147/PRBM.S292958. eCollection 2021.
6
Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).遗传成瘾风险评分(GARS):奖赏缺乏综合征(RDS)易感性的分子神经遗传学证据。
Mol Neurobiol. 2014 Dec;50(3):765-96. doi: 10.1007/s12035-014-8726-5. Epub 2014 May 31.
7
The Future is Now for Precision Genomic Addiction Medicine as a Frontline Modality for Inducing "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).精准基因组成瘾医学作为在奖赏缺乏综合征(RDS)中诱导“多巴胺稳态”的一线治疗手段,未来已来。
Curr Pharm Biotechnol. 2023 Apr 27. doi: 10.2174/1389201024666230427111117.
8
Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?精准行为管理(PBM)和认知控制作为奖赏缺失综合征(RDS)的一种潜在治疗和预防手段:证据是否足够?
Int J Environ Res Public Health. 2022 May 24;19(11):6395. doi: 10.3390/ijerph19116395.
9
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.一种通过纳入遗传成瘾风险严重程度(GARS)和多巴胺稳态恢复来克服“成瘾大流行”的新型精准方法。
J Pers Med. 2021 Mar 16;11(3):212. doi: 10.3390/jpm11030212.
10
Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD).遗传成瘾风险评分(GARS)的生物技术发展以及物质使用障碍(SUD)中纳入多态性等位基因风险的选择性证据。
J Syst Integr Neurosci. 2020 Aug;6(2). doi: 10.15761/JSIN.1000221. Epub 2019 Dec 19.

引用本文的文献

1
A GWAS Meta-meta-analysis and In-depth Silico Pharmacogenomic Investigations in Identification of APOE and Other Genes Associated with Pain, Anti-inflammatory, and Immunomodulating Agents in Opioid Use Disorder (OUD) Derived from 14.91 M Subjects.一项全基因组关联研究的元元分析及深入的电子药物基因组学研究,旨在从1491万名受试者中鉴定与阿片类物质使用障碍(OUD)中疼痛、抗炎和免疫调节药物相关的APOE及其他基因。
Cell Mol Neurobiol. 2025 Jul 31;45(1):76. doi: 10.1007/s10571-025-01587-5.
2
EEG-Spectra-Guided Personalized rTMS in PTSD with Co-occurring Psychiatric Disorders: A Case Series.伴有共病精神障碍的创伤后应激障碍患者的脑电图频谱引导下个性化重复经颅磁刺激:病例系列
Acta Sci Neurol. 2025 Jan 24;8(2):3-9.
3

本文引用的文献

1
Hypothesizing High Negative Emotionality as a Function of Genetic Addiction Risk Severity (GARS) Testing in Alcohol Use Disorder (AUD).假设高负性情绪是酒精使用障碍(AUD)中基因成瘾风险严重程度(GARS)测试的一个函数。
J Syst Integr Neurosci. 2020 Nov 14;7. doi: 10.15761/jsin.1000245.
2
Hypothesizing Molecular Genetics of the Holocaust: Were Dopaminergic Genes Involved or Brain Wash?对大屠杀分子遗传学的假设:多巴胺能基因是否参与其中,还是存在洗脑现象?
SOJ Psychol. 2016 Oct 17;3(2):1-5. doi: 10.15226/2374-6874/3/2/00129.
3
Binge-like Alcohol Exposure in Adolescence: Behavioural, Neuroendocrine and Molecular Evidence of Abnormal Neuroplasticity… and Return.
Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicidal Ideation and Substance Use Disorder.
胰高血糖素样肽-1(GLP1)激动剂的药物基因组学评估及与遗传成瘾风险评分(GARS)相关的途径:对自杀意念和物质使用障碍的影响
Curr Neuropharmacol. 2025;23(8):974-995. doi: 10.2174/011570159X349579241231080602.
4
Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy.解决全球阿片类药物危机:将遗传成瘾风险评估与个性化多巴胺能稳态疗法及意识整合疗法相结合。
J Addict Psychiatry. 2024;8(1):50-95. Epub 2024 Jun 20.
5
Is There a Natural, Non-addictive, and Non-anti-reward, Safe, Gene-based Solution to Treat Reward Deficiency Syndrome? KB220 Variants vs GLP-1 Analogs.是否存在一种天然、无成瘾性、无抗奖赏作用、安全的基于基因的疗法来治疗奖赏缺乏综合征?KB220变体与胰高血糖素样肽-1类似物的比较。
J Addict Psychiatry. 2024;8(1):34-49. Epub 2024 May 20.
6
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies.首例针对多态性多巴胺D2(-DRD2/ANKK(Taq1A))、OPRM1(A/G)、DRD3(C/T)和MAOA(4R)基因缺陷的青春期前男性疑似熊猫症/儿童自身免疫性神经精神障碍相关性疾病患者进行的神经精神症状的首次试点表观遗传类型改善:精准DNA检测及促多巴胺调节(KB220)和抗菌治疗带来的积极临床结果
Open J Immunol. 2024 Sep;14(3):60-86. doi: 10.4236/oji.2024.143006.
7
Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development.通过脑健康检查指导和预防性脑发育来解决青少年的皮质功能失调问题。
INNOSC Theranostics Pharmacol Sci. 2024 Apr 30;7(2):1472. doi: 10.36922/itps.1472.
8
Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography.RDS抗成瘾建模研究总结文档:注释书目
J Addict Psychiatry. 2024 Apr 5;8(1):1-33.
9
Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in Preaddiction.基于证据的临床分析支持遗传成瘾风险严重程度(GARS)评估,以在预测前期早期识别先证者。
EC Psychol Psychiatr. 2024 Dec 26;13(1):1-3.
10
Neurogenetics and Epigenetics of Loneliness.孤独的神经遗传学与表观遗传学
Psychol Res Behav Manag. 2023 Nov 29;16:4839-4857. doi: 10.2147/PRBM.S423802. eCollection 2023.
青少年时期的暴饮式酒精暴露:异常神经可塑性的行为、神经内分泌及分子证据……以及恢复情况。
Biomedicines. 2021 Sep 4;9(9):1161. doi: 10.3390/biomedicines9091161.
4
Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions.在百万退伍军人计划中进行的双祖先抑郁症 GWAS 以及在超过 120 万人中的荟萃分析突出了新的治疗方向。
Nat Neurosci. 2021 Jul;24(7):954-963. doi: 10.1038/s41593-021-00860-2. Epub 2021 May 27.
5
Genetics of substance use disorders: a review.物质使用障碍的遗传学:综述。
Psychol Med. 2021 Oct;51(13):2189-2200. doi: 10.1017/S0033291721000969. Epub 2021 Apr 21.
6
Association of the dopamine D2 receptor rs1800497 polymorphism with food addiction, food reinforcement, and eating behavior in Chilean adults.多巴胺 D2 受体 rs1800497 多态性与智利成年人的食物成瘾、食物强化和饮食行为的关联。
Eat Weight Disord. 2022 Feb;27(1):215-224. doi: 10.1007/s40519-021-01136-1. Epub 2021 Mar 18.
7
High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial.高遗传成瘾风险评分(GARS)在慢性处方重度慢性阿片类药物患者中的应用:一项多痛诊所的开放性临床初步试验。
Mol Neurobiol. 2021 Jul;58(7):3335-3346. doi: 10.1007/s12035-021-02312-1. Epub 2021 Mar 8.
8
Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD).遗传成瘾风险评分(GARS)的生物技术发展以及物质使用障碍(SUD)中纳入多态性等位基因风险的选择性证据。
J Syst Integr Neurosci. 2020 Aug;6(2). doi: 10.15761/JSIN.1000221. Epub 2019 Dec 19.
9
Molecular genetics of substance use disorders: An umbrella review.物质使用障碍的分子遗传学:伞式综述。
Neurosci Biobehav Rev. 2021 May;124:358-369. doi: 10.1016/j.neubiorev.2021.01.019. Epub 2021 Feb 5.
10
Dopamine D4 receptor gene polymorphism (DRD4 VNTR) moderates real-world behavioural response to the food retail environment in children.多巴胺 D4 受体基因多态性(DRD4 VNTR)调节儿童对食物零售环境的真实行为反应。
BMC Public Health. 2021 Feb 3;21(1):145. doi: 10.1186/s12889-021-10160-w.